What question did this study set out to answer?

The aim was to assess changes in intraocular pressure (IOP) with short-term topical and systemic corticosteroid treatments.

Intraocular Pressure During Short-Term Topical or Systemic Corticosteroid Treatment

View Full Paper

Ask AI

Bookmark

Authors

Randomized trials evaluate intraocular pressure in individuals with atopic dermatitis during corticosteroid treatments, suggesting ocular safety.

The aim was to assess changes in intraocular pressure (IOP) with short-term topical and systemic corticosteroid treatments.
Three randomized clinical trials (RCTs) evaluating intraocular pressure changes during corticosteroid treatment.
Participants included individuals with atopic dermatitis and controls, receiving either topical or systemic corticosteroids for varying durations.
Data was analyzed across three studies with a total of 84 participants.
In study 1, right eye IOP decreased significantly by 2.5 mm Hg (95% CI, -3.9 to -1.1; P = 0.002) in patients with AD compared to untreated controls.
In studies 2 and 3, IOP remained stable with no significant changes in either treated or control groups.
Overall, short-term corticosteroid use did not increase IOP, supporting its ocular safety.

Amiri et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Randomized trials evaluate intraocular pressure in individuals with atopic dermatitis during corticosteroid treatments, suggesting ocular safety.